Tert-butyl (R)-2,2-dimethyl-4-(2-oxoethyl)oxazolidine-3-carboxylate, 98%, 250mg

2,4,5-Trifluorobenzenethiol, 1g

Boîtes de Petri divisées en 3 compartiments 10 pièces

2-Aminoisophthalic acid, 97.0%, 100g

Pyridazin-4-ylmethanamine hydrochloride, 95.0%, 100mg

2-Bromo-4-(1,1-difluoroethyl)pyridine, 97%, 250mg

(S)-2-((Tert-butoxycarbonyl)amino)-3-cyclobutylpropanoic acid, 98%, 1g

3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline, 97.0%, 1g

(E)-(2-Nitrovinyl)benzene, 98.0%, 100g

2,6-Dibromobenzothiazole, 95.0%, 5g

N-Cyclopropyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 96%, 5g

2-(pyridin-2-yloxy)benzonitrile, 95.0%, 250mg

(S)-3-Bromo-6-((tert-butyldimethylsilyl)oxy)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine, 98%, 250mg